Predict your next investment

Venture Capital
kudosventures.co.kr

See what CB Insights has to offer

Investments

5

About KUDOS Ventures

KUDOS Ventures, established by financial consulting firm KUDOS, is a venture capital company that focuses on principal investment and incubation & acceleration services.

KUDOS Ventures Headquarter Location

2, Gukjegeumyung-ro 8-gil, Yeongdeungpo-gu 14F

Seoul, 07330,

South Korea

+82 02-6011-7000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest KUDOS Ventures News

D&D Pharmatech Raises $51M in Series C Financing to Advance Phase 2 Clinical Trials for Neurodegenerative, Fibrotic, and Metabolic Diseases

Oct 20, 2021

GAITHERSBURG, Md.--(BUSINESS WIRE)--D&D Pharmatech Inc., a clinical-stage biotechnology company focused on development and commercialization of revolutionary medicines, and parent company of U.S.-based Neuraly Inc., Precision Molecular, Inc., Theraly Fibrosis Inc., P4Microbiome and Valted Seq, today announced that it has completed a $51 million Series C round of financing led by Praxis Capital Partners, a private equity firm that focuses on growth acquisitions and investments in Asia; other investors included DS Asset Management, Kudos Ventures and Korea Investment & Securities. The new round of financing builds upon the $137.1 million the company secured in Series B financing in August 2019. The company is planning an initial public offering in Korea in 2022. “We have been very impressed with the founders and team leaders of D&D and their subsidiaries, as well as their world-class drug development capabilities and ongoing clinical trials” Tweet this “We are grateful for the ongoing support and confidence of our investors and excited to have had Praxis Capital lead this Series C financing,” said Yoo-Seok Hong, Chief Executive Officer of D&D Pharmatech. “We look forward to the ongoing advancement of our clinical candidates in a diverse range of diseases with significant unmet need and the expansion of our... The post D&D Pharmatech Raises $51M in Series C Financing to Advance Phase 2 Clinical Trials for Neurodegenerative, Fibrotic, and Metabolic Diseases appeared first on BioBuzz.

KUDOS Ventures Investments

5 Investments

KUDOS Ventures has made 5 investments. Their latest investment was in Doctor Cha as part of their Seed VC - II on December 12, 2021.

CBI Logo

KUDOS Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/6/2021

Seed VC - II

Doctor Cha

$2.53M

Yes

1

11/22/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

10/19/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

9/3/2020

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Other Investors

Subscribe to see more

Subscribe to see more

10

Date

12/6/2021

11/22/2021

10/19/2021

9/3/2020

Round

Seed VC - II

Series A - II

Series C

Seed VC

Other Investors

Company

Doctor Cha

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$2.53M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.